Epigenetic drug-sensitive biomarkers for cancer
Researchers perform an epigenome-wide multi-omic high-throughput screen to identify actionable epigenetic drug-sensitive biomarkers.
Giovanni Cancemi Shutterstock Communications Biology Giovanni Cancemi Drug Sensitivity Cancer Genome Atlas Cancer Therapeutics Response Portal
Source: news-medical.net